Shrimp Disease Diagnostics
Shrimp Disease Diagnostics Market by Kit (Assay Based Kit, Rapid Testing Kit), Disease (Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus), End User - Global Forecast 2024-2030
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the shrimp disease diagnostics market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[197 Pages Report] The Shrimp Disease Diagnostics Market size was estimated at USD 443.18 million in 2023 and expected to reach USD 478.10 million in 2024, at a CAGR 7.92% to reach USD 755.83 million by 2030.

Shrimp disease refers to various infectious and non-infectious conditions that affect the health, growth, and survival of shrimp in aquaculture systems. These diseases can be caused by various pathogens, such as bacteria, viruses, parasites, and fungi. The shrimp disease diagnostics technologies encompass various diagnostics tools such as morphological pathology (direct light microscopy, histopathology, electron microscopy), enhancement and bioassay methods, traditional microbiology, nucleic acid-based PCR assays, and serological methods to detect the prevalence of disease among shrimp population. The growing global demand for seafood products due to consumer preference for healthier protein sources and rising incidences of abiotic and biotic stresses and chronic diseases among the shrimp population has necessitated the deployment of shrimp disease diagnostics tools. However, the high cost of advanced diagnostic technologies may hinder the adoption of diagnostic tools among small-scale farms or developing countries. Furthermore, the lack of skilled personnel to perform complex diagnostic procedures and the absence of standardized testing protocols for shrimp disease prediction pose hurdles for the adoption of shrimp disease diagnostics strategies. To address these challenges and capitalize on existing opportunities, businesses operating within the shrimp disease diagnostics market should focus on innovation, research-driven product development, and collaboration with stakeholders across the industry. Furthermore, advancements in diagnostic technology and the utilization of nanotechnology for disease diagnosis can propel the growth and adoption of shrimp disease diagnostics.

Regional Insights

In the Americas, particularly Latin America and the Caribbean region, shrimp aquaculture is a major source of income for many coastal communities. The United States also has considerable coastal areas focused on aquaculture and shrimp production. In recent years, there has been an increased focus on implementing biosecurity measures to prevent the spread of diseases such as white spot syndrome virus (WSSV) and early mortality syndrome (EMS). There are some regional companies actively involved in research or product development related to shrimp disease diagnostics, and they offer molecular diagnostic services focused on early identification and management of pathogens affecting shrimps. Asia accounts for a large proportion of global shrimp production among China, India, Thailand, Vietnam, and Indonesia and requires proper diagnostics for this region's growing aquaculture sector. The company scenario in the Asian market is characterized by both international players providing a variety of diagnostic assays and instruments, as well as regional companies that focus on developing innovative solutions tailored to local needs. In Europe, countries, including Spain and France, emphasize biosecurity measures and strict monitoring protocols to prevent the introduction of diseases such as WSSV into their domestic farming operations. European countries contribute significantly to the development and production of advanced diagnostic tools for shrimp diseases. Some European institutions engage in research collaborations with aquaculture stakeholders from other regions to help improve diagnostics capabilities globally.

Shrimp Disease Diagnostics Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Shrimp Disease Diagnostics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Growing shrimp production and export activities worldwide
    • Public-private awareness initiatives and welfare projects to tackle shrimp diseases
    • Regulations for quality shrimp farming and need for efficient disease detection tools
  • Market Restraints
    • Complex testing procedures and need for trained personnel
  • Market Opportunities
    • Advancements in shrimp diagnostics technologies and rapid testing methods
    • New investments in expansion of shrimp farming activities
  • Market Challenges
    • Limitations associated with false positives and inaccuracy of shrimp disease diagnostics
Market Segmentation Analysis
  • Kit: Growing adoption of rapid testing kits for quick and easy detection of pathogens

    Assay-based kits are laboratory-intensive diagnostic tools that utilize techniques such as polymerase chain reaction (PCR), real-time PCR (qPCR), or loop-Mediated isothermal amplification (LAMP) to detect specific pathogens in shrimp samples. These kits offer high sensitivity and specificity in identifying the presence of viral, bacterial, or fungal pathogens. Rapid testing kits are field-deployable diagnostic tools using technologies such lateral flow assays (LFAs) or immunochromatographic test strips, which provide quick and easy-to-read results. Rapid testing kits can be used for qualitative detection of certain infections and pathogens such as white spot syndrome virus and infectious myonecrosis.

  • Disease: Highly contagious nature of white spot syndrome virus (WSSV) necessitating quality PCR and histological tests

    White sport syndrome virus (WSSV) is one of the most devastating diseases affecting shrimp. Diagnostic tools for WSSV include PCR-based tests and antigen detection assays. Early mortality syndrome (EMS), also known as acute hepatopancreatic necrosis disease, is caused by specific strains of vibrio bacteria. Diagnosis for this disease requires molecular techniques, such as PCR and histological examinations. Taura syndrome virus is another significant viral disease in shrimp, which adopts PCR and ELISA for detection. Yellow head virus is also a viral disease and primarily adopts immunological methods for disease detection.

  • End User: Rising incidences of shrimp disease outbreaks in fisheries necessitating deployment of shrimp disease diagnostics strategies

    Aquaculture and marine laboratories play a crucial role in the early diagnosis and management of shrimp diseases. These facilities typically require advanced diagnostic tools, such as polymerase chain reaction (PCR) assays and enzyme-linked immunosorbent assays (ELISA), for the accurate detection and monitoring of various pathogens affecting shrimp populations. Education and research institutes are vital stakeholders in understanding the causes and transmission patterns of shrimp diseases. They often require cost-effective diagnostic methods that can be used for large-scale studies on shrimp diseases. Fisheries represent an essential part of shrimp disease diagnostics end users who seek rapid on-site testing solutions to minimize losses due to outbreaks. Portable devices and handheld PCR instruments are ideal for such applications, as they provide quick results and require minimal technical expertise.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Shrimp Disease Diagnostics Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Shrimp Disease Diagnostics Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Shrimp Disease Diagnostics Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Shrimp Disease Diagnostics Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Shrimp Disease Diagnostics Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Shrimp Disease Diagnostics Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Shrimp Disease Diagnostics Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Shrimp Disease Diagnostics Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Shrimp Disease Diagnostics Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Shrimp Disease Diagnostics Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Shrimp Disease Diagnostics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Shrimp Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • US Project to Develop Low-Cost White Spot Test for Shrimp Farmers

    The US Department of Agriculture (USDA) is investing more than USD 12.5 million into the USDA Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs into Gloucester Marine Genomics Institute (GMGI) and Sherlock Biosciences. Both companies are designing CRISPR based diagnostic tools to quickly detect viruses and other pathogens, eliminating the need for laboratory or expensive equipment. [Published On: 2023-10-10]

  • ViAqua Therapeutics Secures Funding for RNA-based Aquaculture Disease Management

    ViAqua Therapeutics, a biotechnology company, has secured USD 8.25 million in funding to advance the development of their orally administered RNA-particle platform. This innovative technology aims to promote and enhance animal health in aquaculture such as Shrimp that are highly susceptible to diseases. [Published On: 2023-09-06]

  • Aquatreck Signs Research Agreement to Develop Diagnostic Services for Fish Farms

    Aquatreck Animal Health, a Spanish fish vaccine company, has entered into an exclusive research agreement with Biodetect, a diagnostic lab at the University of Patras. The agreement aims to develop a range of innovative diagnostic services for the aquaculture sector, with the goal of enhancing farm vaccination plans and establishing an early warning system for identifying emerging pathogens in the farm environment. [Published On: 2022-10-05]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Shrimp Disease Diagnostics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Shrimp Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3 Little Fish Sdn Bhd, Amazing Biotech, Aquaintech Inc., Arachem (M) Sdn Bhd, Bioneer Corporation, Blue Aqua International Pte. Ltd., CD Genomics, China Guangzhou BioKey Healthy Technology Co. Ltd, DSM Austria GmbH, Forte Biotech, GeneReach Biotechnology Corp., GeneReach Biotechnology Corporation, Genics Pty. Ltd., Illumina, Inc., Innocreate Bioscience Co., Ltd., Lab-Ind Resource Sdn. Bhd., Laboratory Corporation of America Holdings, Mahesh Aqua Holdings (Pvt) Ltd., Mylab Discovery Solutions Pvt. Ltd., PT Riset Nusantara Genetika (Nusantics), Randox Laboratories Ltd., Reagen LLC, Ring Biotechnology Co Ltd., Speedy Assay Sdn. Bhd., SUREBIO, and Thermo Fisher Scientific Inc..

Shrimp Disease Diagnostics Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Kit
    • Assay Based Kit
    • Rapid Testing Kit
  • Disease
    • Early Mortality Syndrome
    • Taura Syndrome Virus
    • White Spot Syndrome Virus
    • Yellow Head or Gill Associated Virus
  • End User
    • Aquaculture & Marine Laboratories
    • Education & Research Institutes
    • Fisheries

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Shrimp Disease Diagnostics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Shrimp Disease Diagnostics Market, by Kit
  7. Shrimp Disease Diagnostics Market, by Disease
  8. Shrimp Disease Diagnostics Market, by End User
  9. Americas Shrimp Disease Diagnostics Market
  10. Asia-Pacific Shrimp Disease Diagnostics Market
  11. Europe, Middle East & Africa Shrimp Disease Diagnostics Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 286]
  16. List of Companies Mentioned [Total: 26]
The Advancements in Shrimp Disease Diagnostics: Rapid Testing Methods and Their Scope
November 14, 2023
BLOG
The Advancements in Shrimp Disease Diagnostics: Rapid Testing Methods and Their Scope
The shrimp industry is one of the most important aquaculture sectors with a huge global demand. Unfortunately, the industry has faced challenges, such as disease outbreaks. Various diseases have affected the shrimp industry in different parts of the world, causing significant economic losses. However, advancements in shrimp disease diagnostics technologies and rapid testing methods have helped to identify and manage these diseases. This blog post discusses the scope of shrimp disease diagnostics and explores the various rapid testing methods available today.

The Importance of Shrimp Disease Diagnostics:

Shrimp disease diagnostics is crucial for the sustainability of the industry and preventing disease outbreaks. Early detection of diseases in shrimp farms can prevent their spread and reduce losses. Proper diagnosis also helps in selecting the appropriate treatment and management strategies. Timely disease diagnostics can provide a better understanding of the prevalence, distribution, and impact of various diseases on the shrimp population.

Traditional vs. Rapid Testing Methods:

Traditional shrimp disease diagnostics require expensive laboratory equipment, highly trained personnel, and a long turnaround time. However, recent advancements in shrimp diagnostics technologies have led to the robust development of rapid testing methods. These newer methods have revolutionized shrimp disease diagnostics by providing more accurate and quicker results, making them more accessible and affordable. The most common rapid testing methods are PCR-based tests, lateral flow assays, and ELISA-based tests.

PCR-Based Tests:

Polymerase chain reaction (PCR)-based tests are molecular diagnostic tools that amplify genetic material in a sample to detect the presence of pathogens. PCR-based tests are ideal for detecting viruses, bacteria, and other pathogens in shrimp farms. PCR-based tests are more sensitive, specific, and reasonably quick when compared to traditional diagnostic tools. They are also useful in identifying diseases that cannot be detected using conventional diagnostic approaches.

Lateral Flow Assays:

Lateral flow assays (LFAs) are immunological assays that can perform rapid detection of specific analytes in a sample. In shrimp disease diagnostics, LFAs can be used to detect different viruses, bacteria, and other pathogens. These tests are simple to use, affordable, and give results in a few minutes. LFAs are ideal for rapid screening and the detection of viral diseases in shrimp farms.

ELISA-Based Tests:

Enzyme-linked immunosorbent assay (ELISA) based tests can identify antibodies or antigens in a sample. These tests are more sensitive than LFAs and can detect lower concentrations of pathogens. These tests are used mostly in the detection and monitoring of parasitic and bacterial diseases in shrimp farms. ELISA-based methods provide highly accurate and reliable results, making them ideal for field-level testing and disease monitoring over time.

Advancements in shrimp disease diagnostics technologies, particularly rapid testing methods, have made shrimp disease diagnoses faster, more accurate, and more affordable. This has led to the better management and control of shrimp diseases, resulting in improved yields and profitability. The rapid tests discussed in this blog post offer tremendous potential to the shrimp industry and can help in the detection of various shrimp diseases at an early stage. With the ongoing technological progress in the field of shrimp diagnostics, the scope for further advancements is enormous.

Frequently Asked Questions
  1. How big is the Shrimp Disease Diagnostics Market?
    Ans. The Global Shrimp Disease Diagnostics Market size was estimated at USD 443.18 million in 2023 and expected to reach USD 478.10 million in 2024.
  2. What is the Shrimp Disease Diagnostics Market growth?
    Ans. The Global Shrimp Disease Diagnostics Market to grow USD 755.83 million by 2030, at a CAGR of 7.92%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.